NCT00946504View on ClinicalTrials.gov

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 31, 1992

Primary Completion Date

October 31, 1992

Study Completion Date

October 31, 1992

Conditions
Type 2 Diabetes
Interventions
DRUG

Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.)

DRUG

Glucotrol 10 mg Tablets (Roerig Pharmaceutical, Inc.)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00946504 - To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets | Biotech Hunter | Biotech Hunter